Skip to main content

Table 1 Demographic and clinical characteristics at baseline of participants by study group

From: Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial

 

bCBT (n = 45)

CAU (n = 43)

Characteristic

n (%)

n (%)

Age

 Mean (SD)

58.0 (11.3)

59.7 (10.0)

Gender

 Male

21 (46.7%)

20 (46.5%)

Education

 Low (ISCED 0–2)

11 (24.4%)

18 (41.9%)

 Middle (ISCED 3–5)

19 (42.2%)

10 (23.3%)

 High (ISCED 6–8)

15 (33.3%)

15 (34.9%)

Employment status

 Paid Employment

17 (37.8%)

17 (39.5%)

 Unemployed

8 (17.8%)

5 (11.6%)

 Voluntary work

4 (8.9%)

8 (18.6%)

 Retired

16 (35.6%)

14 (32.6%)

Primary cancer site

 Breast

18 (40.0%)

18 (41.9%)

 Colorectal

12 (26.7%)

10 (23.3%)

 Prostate

15 (33.3%)

15 (34.9%)

Treatment type

 Surgery

18 (40.0%)

11 (25.6%)

 Radiotherapy

0 (0.0%)

3 (7.0%)

 Surgery + Radiotherapy

9 (20.0%)

9 (20.9%)

 Surgery + Chemotherapy

12 (26.7%)

9 (20.9%)

 Surgery + Radiotherapy + Chemotherapy

6 (13.3%)

11 (25.6%)

Time since diagnosis (years)

 Mean (SD)

2.4 (1.5)

2.8 (1.3)

Time since last treatment (years)

 Mean (SD)

1.9 (1.5)

2.1 (1.4)

Number of comorbid diseases

 0

19 (42.2%)

14 (32.6%)

 1–2

19 (42.2%)

22 (51.2%)

 3+

7 (15.6%)

7 (16.3%)

Psychological help in the past

 yes

22 (50.0%)

26 (60.5%)

  1. Abbreviations: bCBT blended cognitive behaviour therapy, CAU care as usual, ISCED International Standard Classification of Education, SD standard deviation